Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 70 Cyclophosphamide 46 Cisplatin 42 Nivolumab 33 Radiotherapy 30 Paclitaxel 30 Gemcitabine 30 Carboplatin 28 Docetaxel 26 Dexamethasone 22 atezolizumab 20 Blood Specimen Collection 20 Bevacizumab 19 Rituximab 18 Radiosurgery 18 Fluorouracil 18 fludarabine 17 Magnetic Resonance Spectroscopy 17 Leucovorin 17 Lenalidomide 17 Surveys and Questionnaires 16 Oxaliplatin 16 Doxorubicin 15 Irinotecan 14 Etoposide 14 palbociclib 13 Vincristine 13 Radiotherapy, Intensity-Modulated 13 Prednisone 13 Letrozole 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Histocompatibility Testing × 90 days × Clear all

NCT07023822 2026-05-05

WISH, Feasibility of a Factorial Design

The University of Tennessee, Knoxville

Phase NA Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡